Robert J. Alpern - May 9, 2025 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
Director
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for Robert J. Alpern
Stock symbol
ABBV
Transactions as of
May 9, 2025
Transactions value $
$0
Form type
4
Date filed
5/13/2025, 05:05 PM
Previous filing
Apr 29, 2025
Next filing
Jul 1, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Alpern Robert J Director 1 N. WAUKEGAN ROAD, NORTH CHICAGO /s/ T.O. Odutayo, Attorney-in-Fact for Robert J. Alpern 2025-05-13 0001448074

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Award $0 +1.2K +3.49% $0.00 35.6K May 9, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).